Reasons for leaving out were patient unwillingness to participate in the study (n = 12), normalization of ALT during the lead-in phase (n = 10), renal failure (n = 1), and pregnancy or lactation (n = 2). The gene discussed is GPT; the disease is Renal insufficiency.